Matinas BioPharma Holdings, Inc. (MTNB)
1.701
-0.01
(-0.55%)
USD |
NYAM |
Oct 23, 16:00
1.71
+0.01
(+0.55%)
After-Hours: 20:00
Matinas BioPharma Holdings EPS Diluted (Quarterly) : -3.105 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.105 |
| March 31, 2026 | -4.498 |
| December 31, 2025 | -4.477 |
| September 30, 2025 | -5.933 |
| June 30, 2025 | -15.47 |
| March 31, 2025 | -4.883 |
| December 31, 2024 | -24.87 |
| September 30, 2024 | -12.73 |
| June 30, 2024 | -17.20 |
| March 31, 2024 | -20.09 |
| December 31, 2023 | -18.34 |
| September 30, 2023 | -20.90 |
| June 30, 2023 | -20.92 |
| March 31, 2023 | -19.03 |
| December 31, 2022 | -12.57 |
| September 30, 2022 | -18.88 |
| June 30, 2022 | -20.48 |
| March 31, 2022 | -20.69 |
| December 31, 2021 | -23.24 |
| September 30, 2021 | -23.83 |
| June 30, 2021 | -18.19 |
| March 31, 2021 | -19.01 |
| December 31, 2020 | -24.68 |
| September 30, 2020 | -21.40 |
| June 30, 2020 | -21.97 |
| Date | Value |
|---|---|
| March 31, 2020 | -20.42 |
| December 31, 2019 | -26.76 |
| September 30, 2019 | -21.82 |
| June 30, 2019 | -18.91 |
| March 31, 2019 | -27.58 |
| December 31, 2018 | -26.16 |
| September 30, 2018 | -25.80 |
| June 30, 2018 | -30.00 |
| March 31, 2018 | -34.13 |
| December 31, 2017 | -29.14 |
| September 30, 2017 | -28.84 |
| June 30, 2017 | -30.00 |
| March 31, 2017 | -187.50 |
| December 31, 2016 | -24.40 |
| September 30, 2016 | -82.50 |
| June 30, 2016 | -22.50 |
| March 31, 2016 | -30.00 |
| December 31, 2015 | -26.31 |
| September 30, 2015 | -30.00 |
| June 30, 2015 | -30.00 |
| March 31, 2015 | -52.50 |
| December 31, 2014 | -70.70 |
| September 30, 2014 | -60.00 |
| June 30, 2014 | -60.00 |
| March 31, 2014 | -52.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.326M |
| Total Expenses (Quarterly) | 1.326M |
| Enterprise Value | -0.0787M |
| Earnings Yield | -1.06K% |
| Normalized Earnings Yield | -1094.65 |